Anti-(human Growth Factor Receptor Axl)(human Humax-axl .gamma.1-chain) Uses, Dosage, Side Effects and more
Anti-(human Growth Factor Receptor Axl)(human Humax-axl .gamma.1-chain) is under investigation in clinical trial NCT02988817 (Enapotamab Vedotin (Humax-axl-adc) Safety Study in Patients With Solid Tumors).
| Attribute | Details |
|---|---|
| Trade Name | Anti-(human Growth Factor Receptor Axl)(human Humax-axl .gamma.1-chain) |
| Generic | Enapotamab vedotin |
| Enapotamab vedotin Other Names | Enapotamab vedotin, Humax axl adc, HuMax-AXL-ADC, Immunoglobulin g1, anti-(human growth factor receptor axl)(human humax-axl .gamma.1-chain), disulfide with human humax-axl .kappa.-chain, dimer tetrakis(thioether) with vedotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
